Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > AGN expands psychedelic portfolio w/ DMT for TBI study

View:

Post by waves1 on Feb 21, 2023 2:11pm

AGN expands psychedelic portfolio w/ DMT for TBI study

AGN continuing to expand its psychedelic portfolio with the addition of a new clinical research program for the treatment of TBI with DMT!

Using the data from its Phase 1 Study of DMT for Stroke, AGN is able to accelerate to a Phase 2 clinical trial planned for Q4 2023 and AGN will be the first company globally to investigate DMT for TBI in humans.

As the global TBI market is projected to grow from USD $3.1 billion in 2021 to USD $4.5 billion by 2026 at CAGR of 8.0%, this is a significant market opportunity for AGN
https://www.globenewswire.com/news-release/2023/02/21/2611945/0/en/Algernon-NeuroScience-Initiates-Traumatic-Brain-Injury-Research-Program-With-DMT-Appoints-Global-TBI-Expert-as-Advisor.html

146